Vertex Pharmaceuticals (VRTX) EBIT (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted EBIT of $1.25 billion for Q2 2026, up 8.3% from $1.15 billion a year earlier and up 9.6% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EBIT (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Vertex Pharmaceuticals was $4.78 billion, up 21.8% year-over-year; for FY2025, it came in at $4.17 billion.
- Annual EBIT shows a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' EBIT was -$232.9 million in FY2024, $3.83 billion in FY2023 (-11.0%), $4.31 billion in FY2022 (+54.8%) and $2.78 billion in FY2021 (-2.6%).
- The Q2 2026 figure stands as the highest quarterly EBIT in data going back to Q1 2009.
- On a year-over-year basis, EBIT has increased in each of the last four quarters, with growth averaging 11.3% over the last seven quarters.
- The strongest year-over-year quarter for EBIT in the past five years was Q1 2026, with growth of 80.6%; the weakest was Q1 2025, with a decline of 44.7%.
- According to Business Quant data, EBIT for the three prior quarters was $1.14 billion (Q1 2026), $1.21 billion (Q4 2025) and $1.19 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Bn |
| Mar 31, 2026 | 1.14 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.15 Bn |
| Mar 31, 2025 | 630.10 Mn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | -3.51 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 988.50 Mn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 779.00 Mn |
| Dec 31, 2022 | 1.03 Bn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.04 Bn |
| Dec 31, 2021 | 877.70 Mn |
| Sep 30, 2021 | 1.05 Bn |
API Access
Vertex Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();